Editorial: Deprescribing and Minimizing Use of Anticholinergic Medications

Roy L. Soiza, Malaz A. Boustani, Noll L. Campbell, Arduino A. Mangoni

Research output: Contribution to journalEditorial

2 Citations (Scopus)
10 Downloads (Pure)


The global ageing population is increasingly challenged by multi-morbidity resulting in polypharmacy (Soiza 2020). Over the last 2 decades, medications with anticholinergic properties have been particularly strongly associated with a wide range of adverse outcomes (Lowry et al., 2011; Stewart et al., 2021). Despite this, anticholinergic medications have a broad range of indications and continue to be widely prescribed (Bostock et al., 2010). The present challenge is to consider how best to minimize harm from this group of drugs. There is a growing evidence base for the safety and efficacy of deprescribing approaches.
Original languageEnglish
Article number820051
Number of pages2
JournalFrontiers in Pharmacology
Publication statusPublished - Dec 2021


  • anticholinergic
  • antimuscarinic
  • drug safety
  • medication withdrawal
  • medicines optimisation
  • prescribing


Dive into the research topics of 'Editorial: Deprescribing and Minimizing Use of Anticholinergic Medications'. Together they form a unique fingerprint.

Cite this